DE60234604D1 - Orale dosierungsform enthaltend einen therapeutischen wirkstoff und einen gegenwirdenden wirkstoff - Google Patents
Orale dosierungsform enthaltend einen therapeutischen wirkstoff und einen gegenwirdenden wirkstoffInfo
- Publication number
- DE60234604D1 DE60234604D1 DE60234604T DE60234604T DE60234604D1 DE 60234604 D1 DE60234604 D1 DE 60234604D1 DE 60234604 T DE60234604 T DE 60234604T DE 60234604 T DE60234604 T DE 60234604T DE 60234604 D1 DE60234604 D1 DE 60234604D1
- Authority
- DE
- Germany
- Prior art keywords
- active
- dosage form
- therapeutic agent
- oral dosage
- form contains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30979101P | 2001-08-06 | 2001-08-06 | |
US10/208,817 US20030044458A1 (en) | 2001-08-06 | 2002-08-01 | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
PCT/US2002/024889 WO2003013538A1 (en) | 2001-08-06 | 2002-08-05 | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60234604D1 true DE60234604D1 (de) | 2010-01-14 |
Family
ID=26903530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60234604T Expired - Lifetime DE60234604D1 (de) | 2001-08-06 | 2002-08-05 | Orale dosierungsform enthaltend einen therapeutischen wirkstoff und einen gegenwirdenden wirkstoff |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE60234604D1 (de) |
IL (1) | IL160195A0 (de) |
-
2002
- 2002-08-05 DE DE60234604T patent/DE60234604D1/de not_active Expired - Lifetime
- 2002-08-05 IL IL16019502A patent/IL160195A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL160195A0 (en) | 2004-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE550038T1 (de) | Orale darreichungsform enthaltend einen pde-4 hemmer als wirkstoff und polyvinylpyrrolidone als hilfstoff | |
NO20030627L (no) | Hydrogel-drevet medikament doseringsform | |
NO20022970D0 (no) | Hydrogel-drevet medikamentdoseringsform | |
DE60308372D1 (de) | Dosierungsverabreichungsvorrichtung | |
NO20003196L (no) | Umiddelbart opplösende doseringsformulering | |
DE60324099D1 (de) | Arzneistoffhaltiger tampon | |
ITMI20011337A0 (it) | Composizioni farmaceutiche orali a rilascio modificato del principio attivo | |
NO20044054L (no) | Administrering av midler for behandling av betennelse | |
NO20043998L (no) | Oral administreringsform for tungtloselige basiske aktive virkestoffer | |
NO20033384D0 (no) | Farmasöytisk formulering | |
ITTO20010008A0 (it) | Formulazione farmaceutica | |
ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
ATE296619T1 (de) | Feste orale dosierungsform von simethicon | |
ATE409014T1 (de) | Orale behandlungsvorrichtung | |
DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
NO20035627D0 (no) | Farmasöytisk formulering | |
DE60210784D1 (de) | Orale antidiabetische wirkstoffe | |
HK1084843A1 (en) | Health care administration device | |
ITMI20011338A0 (it) | Composizioni farmaceutiche orali a rilascio immediato del principio attivo | |
DE60336999D1 (de) | Melatonin enthaltende pharmazeutische formulierung | |
FR2820311B3 (fr) | Distributeur de medicament portatif | |
DE60139306D1 (de) | N-deacetylthiocolchin-derivate und diese enthaltende arzneimittel | |
DE60234604D1 (de) | Orale dosierungsform enthaltend einen therapeutischen wirkstoff und einen gegenwirdenden wirkstoff | |
NO20004816D0 (no) | Ny farmasøytisk formulering | |
DE60216899D1 (de) | Hormonsubstitutionstherapie und seine darreichungsformen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |